|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |||||
| Loss from impairment of long-lived assets | |||||
| Depreciation and amortization | |||||
| Non-cash lease expense | |||||
| Share-based compensation expense | |||||
| Provision for credit losses | |||||
| Loss on extinguishment of debt | |||||
| Amortization of debt issuance costs and debt discount | |||||
| Loss on write-down and sale of fixed assets | |||||
| Equity in losses of unconsolidated joint venture | |||||
| Remeasurement of warrant liability | |||||
| Change in derivative liability | |||||
| Write-down of note receivable | |||||
| Gain on debt restructuring, net of exchange fees | |||||
| Unrealized (gains) losses on foreign currency transactions | |||||
| Paid-in-kind interest | |||||
| Net change in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Prepaid lease costs, non-current | |||||
| Operating lease liabilities | |||||
| Long-term liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property, plant and equipment | |||||
| Proceeds from sale of fixed assets | |||||
| Purchases of property, plant and equipment held for sale | |||||
| Proceeds from note receivable on assets previously held for sale | |||||
| Payments for investment in joint venture | |||||
| Proceeds from security deposits | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of convertible senior notes | |||||
| Purchase of capped calls related to convertible senior notes | |||||
| Proceeds from issuance of common stock pursuant to the ATM Program, net of issuance costs | |||||
| Proceeds from delayed draw term loans, net of issuance costs | |||||
| Payment of debt issuance costs | |||||
| Repayment of revolving credit facility | |||||
| Payment of equity issuance costs | |||||
| Principal payments under finance lease obligations | |||||
| Proceeds from exercise of stock options | |||||
| Payments of minimum withholding taxes on net share settlement of equity awards | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at the beginning of the period | |||||
| Effect of foreign currency exchange rate changes on cash | |||||
| Cash, cash equivalents and restricted cash at the end of the period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid (received) during the period for: | |||||
| Interest | |||||
| Taxes | |||||
| Non-cash investing and financing activities: | |||||
| Issuance of common stock in conjunction with the exchange of 2027 Notes | |||||
| Re-classification of prepaid issuance costs to additional paid-in-capital related to ATM program | |||||
| Issuance of 2030 Notes in conjunction with the exchange of 2027 Notes, including PIK | |||||
| Conversion of 2030 Notes to common stock | |||||
| Issuance of common stock warrants in connection with delayed draw term loans | |||||
| Non-cash additions to property, plant and equipment | |||||
| Issuance costs of convertible debt, accrued not yet paid | |||||
| Operating lease right-of-use assets obtained in exchange for lease liabilities | |||||
| Reclassification of pre-paid lease costs to finance lease right-of-use assets | |||||
| Reclassification of operating lease right-of-use assets to finance lease right-of-use assets | |||||
| Non-cash addition to financing leases | |||||
Loading...